drugset / Trial / NCT00461032

Montelukast Back to School Asthma Study (0476-340)

NCT00461032

Phase 3 Completed 1162 enrolled Organon and Co
RandomizedParallel-groupDouble-blindTreatment

Summary

This study, in children with chronic asthma, evaluates the number of days of worsening asthma during 8 weeks of treatment with montelukast after treatment is started for the first day of school.

Timeline

Start
2006-06
Primary completion
2006-11
Completion
2006-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Montelukast Other / unclassified 5 mg

Indications